BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20260603T083613EDT-1590aIWXnF@132.216.98.100 DTSTAMP:20260603T123613Z DESCRIPTION:The 91 Research Group on Health and Law (RGHL) invites you to its third seminar of the university year\, delivered by Professor Yann Joly\, DCL'09\, Research Director of the Centre of Genomics and Policy (CG P)\, and Associate Professor at the Faculty of Medicine of 91 Universi ty.\n\nSpace is limited. Kindly RSVP to rghl.law [at] mcgill.ca.\n\nThis e vent is eligible for inclusion as 1.5 hours of continuing legal education as reported by members of the Barreau du Québec. \n\nAbstract\n\nAbout 1.7 % of the Canadian population falls under the umbrella of “intersex”\, incl uding sexual variation at the chromosomal\, gonadal\, hormonal\, and genit al levels. For intersex patients\, healthcare is fraught with difficulties due to the various harms they suffer\, including the concealment of medic al information and trauma due to non-consensual pediatric surgical procedu res.\n\nIn June 2017\, three former US Surgeon Generals published a policy brief recognizing the psychosocial harms caused by the stigmatization of intersex individuals. Furthermore\, in October 2017\, the Parliamentary As sembly of the Council of Europe called for a ban on medically unnecessary 'sex-normalizing' surgical interventions on intersex children. Unfortunate ly\, intersex individuals still face serious human rights violations\, dis crimination\, and stigmatization. Qualitative research\, on which best pra ctices and medical policies can be based to prevent these prejudices\, rem ains underdeveloped. Additionally\, there is presently a lack of Canadian- specific guidance or explicit legal protections to guide healthcare provid ers in their relationship with intersex patients.\n\nThis seminar will pre sent the development of our project on access to healthcare for the inters ex population in Québec and Canada\, focusing on the following aspects: 1) presentation of the main objectives of the project\; 2) challenges posed by research with the intersex community\; 3) identification of foreign law s and policies of interest for the Canadian context\; and 4) a description of the next steps to enable the development of public policies allowing b etter access to healthcare for this marginalized population.\n\nAbout the speaker\n\nYann Joly\, Ph.D. (DCL)\, FCAHS\, Ad.E.\, is the Research Direc tor of the Centre of Genomics and Policy (CGP)\, located inside the Genome Quebec Innovation Centre at 91. He is also an Associate Pr ofessor at the Faculty of Medicine\, Department of Human Genetics cross-ap pointed at the Bioethics Unit\, at 91. Professor Joly is a member of the Canadian Commission for UNESCO (CCU) Sectoral Commission for Natural\, Social and Human Sciences. He is the current Chair of the Bioet hics Workgroup of the International Human Epigenome Consortium (IHEC)\, an d of the Ethics and Governance Committee of the International Cancer Genom e Consortium (ICGC). He is also a member of the Human Genome Organization (HUGO) Committee on Ethics\, Law and Society (CELS). Professor Joly’s rese arch interests lie at the interface of the fields of scientific knowledge\ , health law (biotechnology and other emerging health technologies) and bi oethics.\n DTSTART:20200109T210000Z DTEND:20200109T223000Z LOCATION:Stephen Scott Seminar Room (OCDH 16)\, Chancellor Day Hall\, CA\, QC\, Montreal\, H3A 1W9\, 3644 rue Peel SUMMARY:The Challenges in Access to Healthcare for Intersex Individuals URL:/law/channels/event/challenges-access-healthcare-i ntersex-individuals-303385 END:VEVENT END:VCALENDAR